1. Home
  2. TALK vs TECX Comparison

TALK vs TECX Comparison

Compare TALK & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TALK
  • TECX
  • Stock Information
  • Founded
  • TALK 2012
  • TECX 2019
  • Country
  • TALK United States
  • TECX United States
  • Employees
  • TALK N/A
  • TECX N/A
  • Industry
  • TALK Medical/Nursing Services
  • TECX
  • Sector
  • TALK Health Care
  • TECX
  • Exchange
  • TALK Nasdaq
  • TECX Nasdaq
  • Market Cap
  • TALK 576.9M
  • TECX 647.7M
  • IPO Year
  • TALK N/A
  • TECX 2018
  • Fundamental
  • Price
  • TALK $3.26
  • TECX $47.53
  • Analyst Decision
  • TALK Buy
  • TECX Strong Buy
  • Analyst Count
  • TALK 5
  • TECX 5
  • Target Price
  • TALK $4.38
  • TECX $72.25
  • AVG Volume (30 Days)
  • TALK 1.5M
  • TECX 85.5K
  • Earning Date
  • TALK 10-29-2024
  • TECX 11-07-2024
  • Dividend Yield
  • TALK N/A
  • TECX N/A
  • EPS Growth
  • TALK N/A
  • TECX N/A
  • EPS
  • TALK N/A
  • TECX N/A
  • Revenue
  • TALK $181,291,000.00
  • TECX N/A
  • Revenue This Year
  • TALK $28.09
  • TECX N/A
  • Revenue Next Year
  • TALK $22.76
  • TECX N/A
  • P/E Ratio
  • TALK N/A
  • TECX N/A
  • Revenue Growth
  • TALK 31.50
  • TECX N/A
  • 52 Week Low
  • TALK $1.60
  • TECX $1.40
  • 52 Week High
  • TALK $3.92
  • TECX $53.34
  • Technical
  • Relative Strength Index (RSI)
  • TALK 48.63
  • TECX 54.30
  • Support Level
  • TALK $3.20
  • TECX $47.81
  • Resistance Level
  • TALK $3.64
  • TECX $51.37
  • Average True Range (ATR)
  • TALK 0.16
  • TECX 3.07
  • MACD
  • TALK -0.05
  • TECX -0.90
  • Stochastic Oscillator
  • TALK 11.85
  • TECX 44.82

About TALK Talkspace Inc.

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.

Share on Social Networks: